New IMF reserves could fund vaccinations for low-, middle-income countries: Report

The Rockefeller report said rich countries could reallocate their new Special Drawing Rights (SDRs) to quickly close the funding gap and get more people vaccinated around the world

Reuters
April 06, 2021 / 01:01 PM IST

(File image: AP)

Moves to bolster the IMF's emergency reserves could provide the $44 billion needed to vaccinate 70 percent of the population in lower- and middle-income countries by the end of 2022, at no added cost to rich countries, a new Rockefeller Foundation report finds.

Finance officials from the Group of 20 major economies are expected to back a $650 billion new allocation of the International Monetary Fund's Special Drawing Rights (SDR) this week to help countries cope with the pandemic and its economic fallout.

Vaccination rates and economic development are diverging widely across the globe, according to the IMF and other experts.

The Rockefeller report, to be released Tuesday, said rich countries could reallocate their new SDRs to quickly close the funding gap and get more people vaccinated around the world, preventing virus mutations that could stall a global recovery.

The World Bank estimates that Africa alone would need about $12 billion for COVID-19 vaccines to attain sufficient levels of inoculations to interrupt virus transmission, according to a new paper by the bank and the IMF.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The paper, published Monday, argued for an extension of the Group of 20’s debt service moratorium through year-end, citing the continued high liquidity needs of developing countries and their deteriorating debt sustainability outlooks.

But it said additional resources would be needed, noting that the amount of money Africa needed was about the same as the total amount of official debt service payments already deferred by 45 of the poorest countries participating in the G20’s Debt Service Suspension Initiative (DSSI).

The Rockefeller report noted that high- and upper middle-income countries accounted for 86 percent of COVID-19 shots administered worldwide as of the end of March. It said advanced economies should aim to reallocate at least $100 billion in SDRs to fund the vaccination drive and other measures needed to help poor and middle-income countries.

Donor countries could pledge new SDRs to the IMF’s Poverty Reduction and Growth Trust, which provides loans to 63 low-income countries, but could also provide them to 16 approved institutions, including the World Bank, which could make them more widely available via low- or no-interest loans.

Another option would be for those institutions to use re-allocated SDRs to back the issuance of bonds earmarked specifically for pandemic response and the vaccination drive, the report said.
Reuters
TAGS: #coronavirus #Current Affairs #IMF #World News
first published: Apr 6, 2021 01:01 pm